StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)

Close on Nov 18, 2026Market cap $18.06MP/E –Yield –

Atossa Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Atossa Therapeutics's market cap was $20.26M on Nov 11, 2026, against $100.43M a year earlier. Over the last 5 years it ranged from $16.62M to $225.54M, with a median of $107.21M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$20.26M-73.4%
2025Dec 31, 2025$76.21M-35.6%
2024Dec 31, 2024$118.29M+7.3%
2023Dec 29, 2023$110.26M+64.3%
2022Dec 30, 2022$67.11M-66.9%
2021Dec 31, 2021$202.59M+1938.0%
2020Dec 31, 2020$9.94M-30.7%
2019Dec 31, 2019$14.33M+154.5%
2018Dec 31, 2018$5.63M+54.5%
2017Dec 29, 2017$3.65M-31.7%
2016Dec 30, 2016$5.34M-45.2%
2015Dec 31, 2015$9.74M-72.3%
2014Dec 31, 2014$35.13M-13.2%
2013Dec 31, 2013$40.47M-14.4%
2012Dec 31, 2012$47.27M–

More Atossa Therapeutics figures

See a number that looks wrong?